Loading...

Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors

RAD52 is a member of the homologous recombination (HR) pathway that is important for maintenance of genome integrity. While single RAD52 mutations show no significant phenotype in mammals, their combination with mutations in genes that cause hereditary breast cancer and ovarian cancer like BRCA1, BR...

Full description

Saved in:
Bibliographic Details
Published in:Nucleic Acids Res
Main Authors: Huang, Fei, Goyal, Nadish, Sullivan, Katherine, Hanamshet, Kritika, Patel, Mikir, Mazina, Olga M., Wang, Charles X., An, W. Frank, Spoonamore, James, Metkar, Shailesh, Emmitte, Kyle A., Cocklin, Simon, Skorski, Tomasz, Mazin, Alexander V.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872086/
https://ncbi.nlm.nih.gov/pubmed/26873923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkw087
Tags: Add Tag
No Tags, Be the first to tag this record!